Quick Summary — LCTX scores higher on quality with 6.7/10 vs KYNB's 5.3/10. KYNB trades at $6.84 while LCTX trades at $1.21. Both analyzed daily using SEC EDGAR data across 13 institutional models.
LCTX scores higher with a 6.7/10 quality rating vs KYNB's 5.3/10. Both stocks are analyzed daily using SEC EDGAR filings across 13 independent models.
At $6.84, KYNB trades +132.7% below its Bayesian DCF fair value of $16.17, while LCTX at $1.21 trades +74.2% above its estimate of $0.31. KYNB shows a wider gap between price and intrinsic value.
KYNB earns a Quality of Company score of 5.3/10 compared to LCTX's 6.7/10. This moderate difference suggests one company has an edge in fundamental quality, though both may offer investment merit depending on valuation. The QOC score synthesizes 32 signals spanning profitability margins, revenue growth, free cash flow, capital allocation, and leverage.
KYNB carries a WARN value trap risk (47/100) while LCTX shows SAFE risk (24/100). Stocks with value trap scores above 40 may appear undervalued but face deteriorating fundamentals — declining margins, rising debt, or shrinking revenue can make the apparent discount a trap.
Both KYNB and LCTX operate in Biotechnology, which has 566 stocks tracked by CirclFi. Same-industry comparisons provide the most direct insight into relative valuation since both companies face similar regulatory environments, market dynamics, and competitive pressures. Both companies are analyzed with models spanning intrinsic (Bayesian DCF, EPV), scenario-based (First Chicago), regime-switching (Markov DDM, RCMH-DCF), machine learning (ML-RIV, FTNN), and ensemble methods (CUCE).
11 hidden models compare KYNB vs LCTX differently — including EROIC Spread, First Chicago, Markov DDM, PWERM, and 7 more. Some may disagree with the 2 you see above.
Bloomberg Terminal: ~$2,000/mo · FactSet: ~$1,000/mo · CirclFi: $0.90/day
See All 13 Models — $0.90/dayWe don’t predict prices. We show you what 13 independent mathematical frameworks say a stock is worth — and let you decide.